Grants and Contributions:
Title:
Development of the GoalNav Platform, a Clinical Trial System for Patient-Centric Outcomes Measurement
Agreement Number:
931269
Agreement Value:
$205,475.00
Agreement Date:
Jul 8, 2019 - Mar 18, 2020
Description:
Development of the GoalNav Platform, a clinical trial system for patient-centric outcomes measurement. This data capture system will be robust, secure, and scalable, supporting multiple simultaneous studies, across a mix of therapeutic areas.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Halifax, Nova Scotia, CA B3J 2E3
Reference Number:
172-2019-2020-Q2-931269
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
863915765
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 78 days. The total amended value is 56,475 dollars.
Amendment Date
Dec 13, 2019
Recipient's Legal Name:
DGI Clinical Inc.
Federal Riding Name:
Halifax
Federal Riding Number:
12005
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710
Amendments: